Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-02-19 @ 11:48 AM
Study NCT ID:
NCT02383368
Status:
COMPLETED
Last Update Posted:
2024-10-31
First Post:
2015-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma
Sponsor:
Astellas Pharma Global Development, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
4132-CL-0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None